Comparing PubMatic (NASDAQ:PUBM) & Haoxi Health Technology (NASDAQ:HAO)

PubMatic (NASDAQ:PUBM) and Haoxi Health Technology (NASDAQ:HAO) are both small-cap communication services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Profitability

This table compares PubMatic and Haoxi Health Technology’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PubMatic	-4.66%	-5.41%	-1.99%
Haoxi Health Technology	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings and price targets for PubMatic and Haoxi Health Technology, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PubMatic	1	1	10	0	2.75
Haoxi Health Technology	1	0	0	0	1.00

PubMatic currently has a consensus target price of $18.25, suggesting a potential upside of 9.74%. Given PubMatic’s stronger consensus rating and higher probable upside, equities research analysts plainly believe PubMatic is more favorable than Haoxi Health Technology.

Earnings & Valuation

This table compares PubMatic and Haoxi Health Technology”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PubMatic	$282.93 million	2.68	-$14.46 million	($0.30)	-55.43
Haoxi Health Technology	$32.80 million	0.03	$3.88 million	N/A	N/A

Haoxi Health Technology has lower revenue, but higher earnings than PubMatic.

Risk and Volatility

PubMatic has a beta of 1.54, suggesting that its share price is 54% more volatile than the S&P 500. Comparatively, Haoxi Health Technology has a beta of -1.11, suggesting that its share price is 211% less volatile than the S&P 500.

Institutional and Insider Ownership

64.3% of PubMatic shares are owned by institutional investors. 27.8% of PubMatic shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

PubMatic beats Haoxi Health Technology on 8 of the 12 factors compared between the two stocks.

About PubMatic

PubMatic, Inc., a technology company, engages in the provision of a cloud infrastructure platform that enables real-time programmatic advertising transactions for digital content creators, advertisers, agencies, agency trading desks, and demand side platforms worldwide. Its PubMatic SSP, a sell-side platform, used for the purchase and sale of digital advertising inventory for publishers and buyers. The company also provides solutions, including OpenWrap, a header bidding solution; Openwrap OTT, a prebid-powered unified bidding solution; Openwrap SDK, an enterprise-grade management tools and analytics; Connect, a solution that provides additional data and insights to publishers and buyers; Activate, which allows buyers to execute direct deals on its platform across publisher inventory; Convert, a commerce media solution; and Identity Hub, an ID management tool for publishers that leverages specialized technology?infrastructure?to simplify the complex alternative identifier marketplace. Its platform supports an array of ad formats and digital device types, including mobile app, mobile web, desktop, display, video, over-the-top (OTT), connected television, and media. The company was incorporated in 2006 and is based in Redwood City, California.

About Haoxi Health Technology

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.